Imed Infinity Medical-Limited Partnership (TLV:IMED)

TLV:IMED Statistics

Total Valuation

TLV:IMED has a market cap or net worth of ILS 4.60 million. The enterprise value is -4.59 million.

Market Cap	4.60M
Enterprise Value	-4.59M

Important Dates

The next estimated earnings date is Friday, August 21, 2026.

Earnings Date	Aug 21, 2026
Ex-Dividend Date	n/a

Share Statistics

TLV:IMED has 4.04 million shares outstanding. The number of shares has increased by 55.83% in one year.

Current Share Class	4.04M
Shares Outstanding	4.04M
Shares Change (YoY)	+55.83%
Shares Change (QoQ)	+127.37%
Owned by Insiders (%)	80.51%
Owned by Institutions (%)	19.98%
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	6.38
PB Ratio	0.18
P/TBV Ratio	0.18
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	7.50
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 15.47

Current Ratio	15.47
Quick Ratio	15.47
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -2.50% and return on invested capital (ROIC) is -3.46%.

Return on Equity (ROE)	-2.50%
Return on Assets (ROA)	-3.39%
Return on Invested Capital (ROIC)	-3.46%
Return on Capital Employed (ROCE)	-5.42%
Weighted Average Cost of Capital (WACC)	5.76%
Revenue Per Employee	9,006
Profits Per Employee	-7,651
Employee Count	80
Asset Turnover	0.03
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +21.93% in the last 52 weeks. The beta is 0.27, so TLV:IMED's price volatility has been lower than the market average.

Beta (5Y)	0.27
52-Week Price Change	+21.93%
50-Day Moving Average	118.97
200-Day Moving Average	117.95
Relative Strength Index (RSI)	45.01
Average Volume (20 Days)	7,862

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TLV:IMED had revenue of ILS 720,488 and -612,096 in losses. Loss per share was -0.10.

Revenue	720,488
Gross Profit	720,488
Operating Income	-1.36M
Pretax Income	-612,096
Net Income	-612,096
EBITDA	n/a
EBIT	-1.36M
Loss Per Share	-0.10

Balance Sheet

The company has 9.19 million in cash and n/a in debt, with a net cash position of 9.19 million or 2.28 per share.

Cash & Cash Equivalents	9.19M
Total Debt	n/a
Net Cash	9.19M
Net Cash Per Share	2.28
Equity (Book Value)	25.04M
Book Value Per Share	6.21
Working Capital	8.63M

Cash Flow

Operating Cash Flow	-1.08M
Capital Expenditures	n/a
Depreciation & Amortization	n/a
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 100.00%, with operating and profit margins of -188.50% and -84.96%.

Gross Margin	100.00%
Operating Margin	-188.50%
Pretax Margin	-84.96%
Profit Margin	-84.96%
EBITDA Margin	n/a
EBIT Margin	-188.50%
FCF Margin	n/a

Dividends & Yields

TLV:IMED does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-55.83%
Shareholder Yield	-55.83%
Earnings Yield	-13.31%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TLV:IMED has an Altman Z-Score of 4.04.

Altman Z-Score	4.04
Piotroski F-Score	n/a